About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cardiovascular & Hematological Disorders Drug Targets
›
top-articles
Cardiovascular & Hematological Disorders Drug Targets
0.9
(top 50%)
impact factor
479
(top 50%)
papers
6.0K
(top 20%)
citations
37
(top 20%)
h
-index
0.9
(top 50%)
impact factor
565
all documents
6.3K
doc citations
57
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders Drug Targets
2007
253
2
Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders Drug Targets
2006
142
3
Heparin Induced Thrombocytopenia: Pathogenetic, Clinical, Diagnostic and Therapeutic Aspects
Cardiovascular & Hematological Disorders Drug Targets
2007
127
4
Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders Drug Targets
2008
126
5
Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders Drug Targets
2007
114
6
Renal Endothelial Dysfunction in Acute Kidney Ischemia Reperfusion Injury
Cardiovascular & Hematological Disorders Drug Targets
2014
112
7
Renal Endothelial Dysfunction in Diabetic Nephropathy
Cardiovascular & Hematological Disorders Drug Targets
2014
102
8
Anti-Inflammatory Effects of Different Drugs/Agents with Antioxidant Property on Endothelial Expression of Adhesion Molecules
Cardiovascular & Hematological Disorders Drug Targets
2006
86
9
A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
Cardiovascular & Hematological Disorders Drug Targets
2009
78
10
Na+/Ca2+ Exchange Inhibitors: A New Class of Calcium Regulators
Cardiovascular & Hematological Disorders Drug Targets
2007
76
11
Oxidative Stress and Transforming Growth Factor-.β<sub>1</sub>-induced Cardiac Fibrosis
Cardiovascular & Hematological Disorders Drug Targets
2013
76
12
Neutrophil Migration Under Normal and Sepsis Conditions
Cardiovascular & Hematological Disorders Drug Targets
2015
69
13
Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders Drug Targets
2007
68
14
Pathogenesis of Neointima Formation Following Vascular Injury
Cardiovascular & Hematological Disorders Drug Targets
2011
67
15
Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders Drug Targets
2008
66
16
Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification
Cardiovascular & Hematological Disorders Drug Targets
2009
64
17
Adipose Tissue: The Link Between Obesity and Cardiovascular Disease
Cardiovascular & Hematological Disorders Drug Targets
2008
62
18
Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders Drug Targets
2006
59
19
Glucose-6-Phosphate Dehydrogenase Deficiency: Disadvantages and Possible Benefits
Cardiovascular & Hematological Disorders Drug Targets
2013
58
20
Human Apolipoprotein C-III – A New Intrahepatic Protein Factor Promoting Assembly and Secretion of Very Low Density Lipoproteins
Cardiovascular & Hematological Disorders Drug Targets
2012
57
21
Immunomodulatory and Anti-inflammatory Effects of Thymoquinone
Cardiovascular & Hematological Disorders Drug Targets
2018
55
22
Complications of Infective Endocarditis
Cardiovascular & Hematological Disorders Drug Targets
2009
54
23
Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer Patients
Cardiovascular & Hematological Disorders Drug Targets
2010
52
24
Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms
Cardiovascular & Hematological Disorders Drug Targets
2012
52
25
Glucagon-Like Peptide-1 as a Key Regulator of Lipid and Lipoprotein Metabolism in Fasting and Postprandial States
Cardiovascular & Hematological Disorders Drug Targets
2014
45
26
Endothelial Progenitors in Vascular Repair and Angiogenesis: How Many are Needed and What to do?
Cardiovascular & Hematological Disorders Drug Targets
2008
44
27
Risk Factors and Mediators of the Vascular Dysfunction Associated with Hypertension in Pregnancy
Cardiovascular & Hematological Disorders Drug Targets
2010
44
28
Medial Vascular Calcification in Diabetes Mellitus and Chronic Kidney Disease: The Role of Inflammation
Cardiovascular & Hematological Disorders Drug Targets
2007
43
29
Targeting Adhesion Molecules in Cardiovascular Disorders
Cardiovascular & Hematological Disorders Drug Targets
2008
43
30
Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma
Cardiovascular & Hematological Disorders Drug Targets
2013
42
31
The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
Cardiovascular & Hematological Disorders Drug Targets
2018
42
32
Mitochondrial Dysfunction, Oxidative Stress and Diabetic Cardiovascular Disorders
Cardiovascular & Hematological Disorders Drug Targets
2012
42
33
Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation
Cardiovascular & Hematological Disorders Drug Targets
2009
41
34
Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy
Cardiovascular & Hematological Disorders Drug Targets
2009
41
35
Involvement of Hypoxia-Inducible Factors in the Dysregulation of Oxygen Homeostasis in Sepsis
Cardiovascular & Hematological Disorders Drug Targets
2015
41
36
Cardiolipin Metabolism and the Role it Plays in Heart Failure and Mitochondrial Supercomplex Formation
Cardiovascular & Hematological Disorders Drug Targets
2014
41
37
Neuroinflammation in Sepsis: Sepsis Associated Delirium
Cardiovascular & Hematological Disorders Drug Targets
2015
40
38
Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders Drug Targets
2015
40
39
Diabetes, Hyperglycemia and Accelerated Atherosclerosis: Evidence Supporting a Role for Endoplasmic Reticulum (ER) Stress Signaling
Cardiovascular & Hematological Disorders Drug Targets
2010
39
40
Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysis
Cardiovascular & Hematological Disorders Drug Targets
2013
38
41
Citrus Flavonoids and the Prevention of Atherosclerosis
Cardiovascular & Hematological Disorders Drug Targets
2012
37
42
Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders Drug Targets
2008
36
43
Atrial Fibrillation: The Emerging Role of Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders Drug Targets
2010
36
44
Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders Drug Targets
2006
35
45
Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders Drug Targets
2008
35
46
Cardiovascular Disease: What's All the AGE/RAGE About?
Cardiovascular & Hematological Disorders Drug Targets
2010
34
47
Nanoparticle Based Treatment for Cardiovascular Diseases
Cardiovascular & Hematological Disorders Drug Targets
2019
34
48
Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management
Cardiovascular & Hematological Disorders Drug Targets
2010
33
49
Vascular C-Reactive Protein in the Pathogenesis of Coronary Artery Disease:Role of Vascular Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders Drug Targets
2006
33
50
Novel Insights Into Lp(a) Physiology and Pathogenicity: More Questions Than Answers?
Cardiovascular & Hematological Disorders Drug Targets
2006
33
site/software ©
exaly
; All materials licenced under
CC by-SA
.